| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | EAGLE PHARMACEUTICALS INC COM | 4,780,188 | 185,423,000 | 75.43% | ||
| 2 | Agile Therapeutics, Inc. | 5,062,363 | 38,525,000 | 15.67% | ||
| 3 | IMMUNE DESIGN CORP COM | 1,962,720 | 16,016,000 | 6.51% | ||
| 4 | ANTHERA PHARMACEUTICALS I | 1,900,000 | 5,871,000 | 2.39% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000932440-16-000454, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
